Incyte Corp
Nasdaq · Healthcare · Services-Commercial Physical & Biological Research · Wilmington, DE
INCY chart
What traders are saying about $INCY
Latest postsIncyte Corp news
- Incyte at Wolfe research healthcare conference: growth plan takes shape By Investing.com
Investing.com UK ·
- Natera, Incyte Collaborate on Interventional Phase II Study in Colorectal Cancer
GenomeWeb ·
- Natera, Incyte partner on colorectal cancer trial using MRD test By Investing.com
Investing.com India ·
- Natera and Incyte team up on phase II colorectal cancer trial
StreetInsider ·
- Natera Announces Clinical Collaboration with Incyte on Interventional Phase II Study in Colorectal Cancer
Yahoo Finance ·
- A cancer test will help identify high-risk patients for a colorectal cancer study
Stock Titan ·
- Incyte Raises Sales Outlook as Drug Revenue Climbs 14%
MyChesCo ·
- Raised Sales Guidance Could Be A Big Test For Incyte Stock (INCY)
Simply Wall St ·
- 2026 Incyte Ingenuity Awards in GVHD™ Awarded to University of Maryland School of Medicine and H. Lee Moffitt Cancer Center & Research Institute
BioSpace ·
- Incyte Advances Pancreatic and Colorectal Cancer Drug Trials
MyChesCo ·
- Form 144 INCYTE CORPORATION For: 7 November By Investing.com
Investing.com Canada ·
- Incyte Corporation (INCY) Options Chain - Yahoo Finance
Yahoo! Finance Canada ·
Incyte Corp key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $5.14B | $4.24B | $3.70B | $3.39B |
| Net income | $1.29B | $32.6M | $597.6M | $340.7M |
| Diluted EPS | $6.41 | $0.15 | $2.65 | $1.52 |
| Total assets (year end) | $6.96B | $5.44B | $6.78B | $5.84B |
| Cash and equivalents (year end) | $3.10B | $1.69B | $3.21B | $2.95B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Incyte Corp
- Ticker
- INCY (Nasdaq)
- Industry
- Services-Commercial Physical & Biological Research
- Headquarters
- Wilmington, DE
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 879169
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
Frequently asked questions
What exchange is Incyte Corp listed on?
Incyte Corp trades on the Nasdaq under the ticker symbol INCY.
What industry is Incyte Corp in?
Incyte Corp is classified by the SEC under "Services-Commercial Physical & Biological Research", part of the Healthcare sector on StockTweeting.
Where is Incyte Corp headquartered?
Incyte Corp's business address on file with the SEC is in Wilmington, DE.
When does Incyte Corp's fiscal year end?
Incyte Corp's fiscal year ends on December 31.
How much revenue did Incyte Corp report?
Incyte Corp reported $5.14B in revenue for calendar year 2025, according to its SEC filings.